at 10 Years: Two Imperatives
article has not abstract
Vyšlo v časopise:
at 10 Years: Two Imperatives. PLoS Med 11(10): e32767. doi:10.1371/journal.pmed.1001749
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001749
Souhrn
article has not abstract
Zdroje
1. EisenMB, BrownPO, VarmusHE (2004) PLoS Medicine—A Medical Journal for the Internet Age. PLoS Med 1: e31 doi:10.1371/journal.pmed.0010031
2. The PLoS Medicine Editors (2004) Prescription for a Healthy Journal. PLoS Med 1: e22 doi:10.1371/journal.pmed.0010022
3. PLoS Medicine (2014) PLoS Medicine Disease Mongering Collection. Available: http://www.ploscollections.org/article/browse/issue/info%3Adoi%2F10.1371%2Fissue.pcol.v07.i02. Accessed 23 September 2014.
4. PLoS Medicine (2014) PLoS Medicine Ghostwriting Collection. Available: http://www.ploscollections.org/article/browse/issue/info%3Adoi%2F10.1371%2Fissue.pcol.v07.i15. Accessed 23 September 2014.
5. PLoS Medicine (2014) PLoS Medicine Series on Big Food. Available: http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v07.i17. Accessed 23 September 2014.
6. UlucanlarS, FooksGJ, HatchardJL, GilmoreAB (2014) Representation and Misrepresentation of Scientific Evidence in Contemporary Tobacco Regulation: A Review of Tobacco Industry Submissions to the UK Government Consultation on Standardised Packaging. PLoS Med 11: e1001629 doi:10.1371/journal.pmed.1001629
7. IoannidisJPA (2005) Why Most Published Research Findings Are False. PLoS Med 2: e124 doi:10.1371/journal.pmed.0020124
8. SchulzKF, AltmanDG, MoherD (2010) the CONSORT Group (2010) CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials. PLoS Med 7: e1000251 doi:10.1371/journal.pmed.1000251
9. MoherD, LiberatiA, TetzlaffJ, AltmanDG (2009) the PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6: e1000097 doi:10.1371/journal.pmed.1000097
10. BloomT, GanleyE, WinkerM (2014) Data Access for the Open Access Literature: PLOS's Data Policy. PLoS Med 11: e1001607 doi:10.1371/journal.pmed.1001607
11. The PLoS Medicine Editors (2014) Observational Studies: Getting Clear about Transparency. PLoS Med 11: e1001711 doi:10.1371/journal.pmed.1001711
12. The PLoS Medicine Editors (2006) The Impact Factor Game. PLoS Med 3: e291 doi:10.1371/journal.pmed.0030291
13. American Society for Cell Biology (2013) San Francisco Declaration on Research Assessment. Available: http://www.ascb.org/dora/. Accessed 3 September 2014.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 10
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
- Developmental Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies
- Maternal Clinical Diagnoses and Hospital Variation in the Risk of Cesarean Delivery: Analyses of a National US Hospital Discharge Database
- Association of Medical Students' Reports of Interactions with the Pharmaceutical and Medical Device Industries and Medical School Policies and Characteristics: A Cross-Sectional Study